fda warning letter bpc 157 2024 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Compliance for Peptide Therapy
Description
With a grey-market, self-injected product, identity and sterility are not assumptions you get to make for free
Note: if using a 3ml/cc mixing syringe steps 2 - 6 will need to be completed several times to transfer all the fluid into the powder
Weakness and fatigue
Its relatively rare, but when it does happen, the affected patient tends to develop degenerative spinal issues sooner in life than usual
Ornoy et al., 2016
